Literature DB >> 1680537

Levocabastine eye drops versus sodium cromoglycate in seasonal allergic conjunctivitis.

J A Wihl1, S Rudblad, H Kjellén, L A Blychert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1680537     DOI： 10.1111/j.1365-2222.1991.tb01756.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  5 in total

Review 1.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  The antihistamines of the nineties.

Authors:  M M Janssens; P H Howarth
Journal:  Clin Rev Allergy       Date:  1993

Review 3.  The pharmacokinetic properties of topical levocabastine. A review.

Authors:  J Heykants; A Van Peer; V Van de Velde; E Snoeck; W Meuldermans; R Woestenborghs
Journal:  Clin Pharmacokinet       Date:  1995-10       Impact factor: 6.447

Review 4.  Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.

Authors:  S Noble; D McTavish
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

Review 5.  Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness.

Authors:  Christopher G Owen; Anupa Shah; Katherine Henshaw; Liam Smeeth; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2004-06       Impact factor: 5.386
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.